Transdel Targeting Cellulite In ’09 While Finishing Trials For Anti-Pain Drug
This article was originally published in The Rose Sheet
Executive Summary
Transdel Pharmaceuticals is targeting an underserved segment of the cosmeceutical market - anti-cellulite - under its expanded R&D program, and aims to launch its product before year-end
You may also be interested in...
Dr. H. Bellin Targets Stretch Marks, Scars With Cream Featuring Edelweiss
Aimed at "dramatically reducing the appearance of stretch marks and scars," Dr. H. Bellin Swiss Skin Care launches Scar & Stretch Mark Body Cream, which uses Swiss edelweiss extract to stimulate skin cell regeneration.
Dr. H. Bellin Targets Stretch Marks, Scars With Cream Featuring Edelweiss
Aimed at "dramatically reducing the appearance of stretch marks and scars," Dr. H. Bellin Swiss Skin Care launches Scar & Stretch Mark Body Cream, which uses Swiss edelweiss extract to stimulate skin cell regeneration.
Vichy's CelluDestock Enlists Fat-Busting Protein To Break Down Cellulite
Vichy Laboratories is promoting its CelluDestock Intensive Treatment as a novel anti-cellulite cream that works by stimulating a protein in cells responsible for the breakdown of excess fat tissue